Develops genetic sequencing products for researchers and doctors.
Jun 2026Revenue $4.49B/yrExpenses $3.61B/yr
No trend
Figures by year
Is Illumina profitable?
Yes. In the 12 months to Jun 2026, revenue was $4.49B and expenses $3.61B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $4.34B | $3.54B | $807M |
| Dec 2024 | $4.37B | $5.21B | −$833M |
| Dec 2023 | $4.50B | $5.57B | −$1.07B |
| Jan 2023 | $4.58B | $8.76B | −$4.18B |
| Jan 2022 | $4.53B | $4.65B | −$123M |
| Jan 2021 | $3.24B | $2.66B | $580M |
| Dec 2019 | $3.54B | $2.56B | $985M |
| Dec 2018 | $3.33B | $2.45B | $883M |
| Dec 2017 | $2.75B | $2.15B | $606M |
| Jan 2017 | $2.40B | $1.81B | $587M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.